Metformin can inhibit tumor in many ways, including regulating the PI3K (phosphatidylinositol 3-kinase), mammalian target of rapamycin (mTOR), AMP-activated protein kinase, and MAPK (mitogen-activated protein kinase) signaling pathways [50, 51]. The gene discussed is WNK2; the disease is neoplasm.